LifeStance Health Group, Inc. (NASDAQ:LFST) COO Gwen H. Booth Sells 88,798 Shares of Stock

LifeStance Health Group, Inc. (NASDAQ:LFSTGet Rating) COO Gwen H. Booth sold 88,798 shares of the business’s stock in a transaction dated Monday, June 13th. The shares were sold at an average price of $5.27, for a total value of $467,965.46. Following the completion of the transaction, the chief operating officer now directly owns 7,083,637 shares in the company, valued at $37,330,766.99. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shares of LFST opened at $6.01 on Wednesday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.10 and a current ratio of 2.10. The stock has a 50 day moving average price of $7.99 and a two-hundred day moving average price of $8.64. The firm has a market capitalization of $2.25 billion and a P/E ratio of -5.62. LifeStance Health Group, Inc. has a 52 week low of $4.77 and a 52 week high of $29.81.

LifeStance Health Group (NASDAQ:LFSTGet Rating) last issued its quarterly earnings data on Monday, May 9th. The company reported ($0.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.03). The company had revenue of $203.10 million for the quarter, compared to the consensus estimate of $191.47 million. LifeStance Health Group had a negative return on equity of 22.41% and a negative net margin of 49.60%. LifeStance Health Group’s quarterly revenue was up 41.9% on a year-over-year basis. On average, equities analysts forecast that LifeStance Health Group, Inc. will post -0.48 earnings per share for the current year.

A number of analysts recently commented on the company. The Goldman Sachs Group decreased their target price on LifeStance Health Group from $15.00 to $10.00 and set a “neutral” rating for the company in a research report on Monday, March 21st. UBS Group lowered LifeStance Health Group from a “buy” rating to a “neutral” rating and decreased their target price for the company from $19.00 to $10.00 in a research report on Thursday, March 17th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $16.00.

Institutional investors and hedge funds have recently modified their holdings of the business. Koshinski Asset Management Inc. bought a new stake in LifeStance Health Group during the 4th quarter worth approximately $34,000. Royal Bank of Canada grew its holdings in shares of LifeStance Health Group by 39,407.1% in the third quarter. Royal Bank of Canada now owns 5,531 shares of the company’s stock valued at $80,000 after acquiring an additional 5,517 shares in the last quarter. Citigroup Inc. grew its holdings in shares of LifeStance Health Group by 552.5% in the third quarter. Citigroup Inc. now owns 5,546 shares of the company’s stock valued at $80,000 after acquiring an additional 4,696 shares in the last quarter. Ameritas Investment Partners Inc. grew its holdings in shares of LifeStance Health Group by 56.6% in the first quarter. Ameritas Investment Partners Inc. now owns 5,575 shares of the company’s stock valued at $56,000 after acquiring an additional 2,016 shares in the last quarter. Finally, Bank of America Corp DE bought a new position in shares of LifeStance Health Group in the second quarter valued at approximately $200,000. 80.71% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile (Get Rating)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Featured Articles

Insider Buying and Selling by Quarter for LifeStance Health Group (NASDAQ:LFST)

Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.